» Articles » PMID: 2165453

Importance of Retinal Pigmentation As a Subclinical Marker in Familial Adenomatous Polyposis

Overview
Specialty Gastroenterology
Date 1990 Aug 1
PMID 2165453
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Surgery was performed in 35 patients with familial adenomatous polyposis (FAP) from 22 family trees. To clarify retinal pigmentation as an important subclinical marker in patients with FAP, precise retinal examinations were performed in 41 cases (82 eyes), including 23 patients and 18 family members including 12 second-generation and third-generation possible carriers. In 27 patients, precise studies were done on accompanying lesions, and the number of polyps was counted at the time of surgery in each patient in every family tree. The overall incidence of retinal pigmentation in patients was 82.6 percent. The incidence of retinal pigmentation in possible carriers was found to be 50 percent, which is comparable with the calculated expressibility of the polyps. The shape and distribution of pigmentations were classified into two categories--large and small. A total of 1984 control retinal examinations were performed, which revealed only six retinal pigmentations (0.3 percent). In the control group, all pigmentation was solitary and unilateral. No large pigmentations in bilateral eyes were found in the control group. In large pigmentation, the sensitivity and specificity were calculated as 0.652 and 0.999, respectively, and in small pigmentation, the sensitivity and specificity were calculated as 0.783 and 0.997, respectively. Small pigmentation appears to increase in number around the age of the appearance of the polyp. Earliest recognition of the pigmentation in this series was one year of age.

Citing Articles

Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP): Systematic Literature Review and Screening Recommendations.

Bonnet L, Conway R, Lim L Clin Ophthalmol. 2022; 16:765-774.

PMID: 35321042 PMC: 8934868. DOI: 10.2147/OPTH.S354761.


Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer.

Chen C, Phillips K, Grist S, Bennet G, Craig J, Muecke J Fam Cancer. 2006; 5(4):397-404.

PMID: 16944273 DOI: 10.1007/s10689-006-0011-y.


Value of the congenital hypertrophy of the retinal pigment epithelium in the diagnosis of familial adenomatous polyposis.

Tourino R, Conde-Freire R, Cabezas-Agricola J, Rodriguez-Aves T, Lopez-Valladares M, Otero-Cepeda J Int Ophthalmol. 2004; 25(2):101-12.

PMID: 15290889 DOI: 10.1023/b:inte.0000031739.62559.ac.


Ocular findings in familial adenomatous polyposis.

Gelisken O, Yucel A, Guler K, Zorluoglu A Int Ophthalmol. 1997; 21(4):205-8.

PMID: 9700007 DOI: 10.1023/a:1005957406770.


Diagnostic value of fundus examination in familial adenomatous polyposis.

Tiret A, Tiret E, Laroche L Br J Ophthalmol. 1998; 81(9):755-8.

PMID: 9422927 PMC: 1722327. DOI: 10.1136/bjo.81.9.755.